Chronic migraine sufferers taking GLP-1 drugs were about 10% less likely to need ER care for a migraine attack compared to those taking a standard first-line migraine drug, researchers are scheduled ...

The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded study.

Between four and 10 million people in the U.S. have fibromyalgia. Many doctors look askance at the disorder, leading some patients to seek pain relief from substance use.

Preliminary study finds GLP-1 drugs (semaglutide, etc.) are associated with 10% fewer emergency visits and lower medication use for chronic migraine patients.

The COVID-19 pandemic caused a spike in the number of people turning to medication to help relieve anxiety but top health ...

Families in Kensington and beyond are grappling with a crisis shaped by migration, disinvestment, and a public health response that many say has failed them.

Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and ...

Key points A 4-year-old boy presented to our urgent ophthalmology clinic for photophobia and persistent eye rubbing. He had been born at 39 weeks via Cesarean delivery, without complications. Prenatal ...

PYRUKYND is the only medicine approved in the UAE for adults with non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia NewBridge Pharmaceuticals, a regional specialty company ...

Since President Donald Trump issued a July 2025 executive order aimed at “ending crime and disorder on America’s streets,” national attention has increasingly focused on involuntary treatment as a ...

Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...